Brain Tumor as a Late Outcome of a Child with Nephrotic Syndrome - Is There Any Association with Immunosuppression?
Journal of Pediatric Nephrology,
Vol. 2 No. 2 (2014),
9 May 2014
,
Page 79-82
https://doi.org/10.22037/jpn.v2i2.5417
Abstract
The association of idiopathic nephrotic syndrome with some malignancies has been reported. We hereunder report a child with focal segmental sclerosis who presented with brain tumor eleven years after renal presentation. A 16- year-old boy presented with nephrotic syndrome since was 5 years old. He was a steroid responder at first but became steroid dependent after subsequent relapses. He received cyclosporine for two years and then mycophenolate mofetil was added for three years. After that, he received losartan and enalapril. Four years later, he developed glioblastoma multiforme. He passed away two years after surgical resection and chemo-radiotherapy. The occurrence of brain tumor after immunosuppressive therapy in this child might be a late sequel or a coincidence. This might be an alarm for using immunosuppressive agents more cautiously.
Keywords: Glioblastoma; Immunosuppression; Mycophenolate Mofetil; Cyclosporine; Losartan; Enalapri; Nephrotic Syndrome.
How to Cite
References
Dasgupta N, Gelber AC, Racke F, Fine DM. Central nervous system lymphoma associated with mycophenolate mofetil in lupus nephritis. Lupus. 2005;14:910-913.
Svobodova B, Hruskova Z, Rysava R, Tesar V. Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil. Lupus. 2011;20:1452-1454.
Olowu WA, Salako AA, Adelusola KA, Sowande OA, Adetiloye VA, Adefehinti O, Osasan SA. Focal segmental glomerulosclerosis and nephrotic syndrome in a child with embryonal rhabdomyosarcoma. Clin Exp Nephrol. 2008;12:144-148.
Buglyó G, Méhes G, Vargha G, Biró S, Mátyus J.WT1 microdeletion and slowly progressing focal glomerulosclerosis in a patient with male pseudohermaphroditism, childhood leukemia, Wilms tumor and cerebellar angioblastoma. Clin Nephrol. 2013;79:414-418.
Iijima K, Someya T, Ito S, et.al .Focal segmental glomerulosclerosis in patients with complete deletion of one WT1 allele. Pediatrics. 2012;129 :e1621-5.
Yamauchi J, Ubara Y, Suwabe T. Focal segmental glomerulosclerosis associated with invasive thymoma. Ther Apher Dial. 2011;15:210-211.
González García E, Olea T, Hevia C, et. al. Focal segmental glomerulosclerosis due to a relapsing non-Hodgkin's lymphoma diagnosed by positron emission tomography. J Nephrol. 2007 ;20:626-628.
Penn I, Starzl TE. Immunosuppression and Cancer. Transplant Proc. 1973; 5(1): 943–947.
Kaminska B, Tyburczy M, Gabrusiewicz K, Sielska M. Glioblastoma: Anti-tumor Action of Cyclosporin A and Functionally Related Drugs. In: Hayat MA. Tumors of The Central Nervous System. Springer, 20011, p 241-253.
Blaheta RA, Bogossian H, Beecken WD, et.al. Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro. Transplantation. 2003;76: 1735-1741.
Robson R, Cecka JM, Opelz G, Budde M, Sacks S. Prospective registry-based observational cohort study of the long- term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant. 2005;5:2954-2960.
O'Neill JO, Edwards LB, Taylor DO. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006 ;25:1186-1191.
Schrem H, Kurok M, Kaltenborn A, et.al .Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection. Liver Transpl. 2013. doi: 10.1002/lt.23722.
Rao GA, Mann JR, Shoaibi A, et.al. Angiotensin receptor blockers: are they related to lung cancer? J Hypertens. 2013;31:1669-1675.
Hooman N, Hallaji F, Mehrazma M. Brain Tumor as a Late Outcome of a Child With Nephrotic Syndrome, Is It any Association With Mycophenolate Mofetile? Iran J Kidney Dis. 2011; 5:Suppl. 1: 6 (Abstract).
Hooman N, Hallaji F, Mehrazma M. Brain Tumor as a Late Outcome of a Child With Nephrotic Syndrome, Is It any Association With Mycophenolate Mofetile? Pediatr Nephrol.2011; 26: 1638. (Abstract)
- Abstract Viewed: 383 times
- PDF Downloaded: 231 times